Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sigrid P M A Oomen"'
Autor:
Virgil A. S. H. Dalm, Sigrid P M A Oomen, Leo J. Hofland, Steven W. J. Lamberts, Diana M. Mooij, Elgin G. R. Lichtenauer-Kaligis, P. Martin van Hagen
Publikováno v:
European Journal of Endocrinology, 150, 565-577. Bioscientifica Ltd
BACKGROUND: Somatostatin (SS)-binding sites have been demonstrated in human lymphoid tissues and peripheral blood cells. However, not much is known with respect to the SS receptor subtype (sst) expression pattern and the expression of SS itself in th
Autor:
Sigrid P M A Oomen, Paula B. van Hennik, Leo J. Hofland, Ivo P. Touw, Steven W. J. Lamberts, Claudia Antonissen, Bob Löwenberg, Elgin G. R. Lichtenauer-Kaligis
Publikováno v:
Experimental Hematology, 30(2), 116-125. Elsevier Inc.
Objective Somatostatin (SST) is a regulatory peptide with a wide variety of activities in different tissues. SST activates G αi -protein-coupled receptors of a family comprising five members (SSTR1–5). Despite the broad use of SST and its analogs
Autor:
Ivo P. Touw, Leo J. Hofland, Steven W. J. Lamberts, Sigrid P M A Oomen, Alister C. Ward, Bob Löwenberg
Publikováno v:
Hematology Journal, 2, 322-329. Ferrata Storti Foundation
Introduction: Somatostatin, originally identified as a peptide involved in neurotransmission, functions as an inhibitor of multiple cellular responses, including hormonal secretion and proliferation. Somatostatin acts through activation of G-protein-
Publikováno v:
European Journal of Endocrinology. :S9-14
Objective. Somatostatin (SST) is a regulatory peptide with a wide variety of activities in different tissues. SST activates G00-protein-coupled receptors of a family comprising five members (SSTRl-5). Despite the broad use of SST and its analogs in c
Autor:
Taolin Yi, D. van Leeuwen, Claudia A.J. Erpelinck-Verschueren, Touw I, Judith Gits, Louise Smith, A. A. Soede-Bobok, Sigrid P M A Oomen, Alister C. Ward
Publikováno v:
Leukemia. 14:1284-1291
The SH2 domain-containing protein tyrosine phosphatase SHP-1 is expressed widely in the hematopoietic system. SHP-1 has been shown to negatively control signal transduction from many cytokine receptors by direct docking to either the receptor itself,
Publikováno v:
FEBS Letters. Journal for the Rapid Publication of Short Reports in Biochemistry ....., 503, 163-167. Wiley-Blackwell
The regulatory peptide somatostatin (SST) acts via a family of G-protein-coupled receptors comprising five subtypes (SSTR1–5). G-protein-coupled receptors activate multiple signaling mechanisms, which variably depend on internalization and intracel
Autor:
Johannes Hofland, Sigrid P M A Oomen, Bob Löwenberg, Elgin G. R. Lichtenauer-Kaligis, Ivo P. Touw, Steven W. J. Lamberts, N. Verplanke
Publikováno v:
Leukemia. 15(4)
Somatostatin, a neuropeptide with multiple activities, exerts its function via G-coupled membrane receptors. Five somatostatin receptor subtypes, sst1–5, have been identified. We have recently established that somatostatin acts as a chemoattractant
Autor:
Elgin G R Lichtenauer-Kaligis, Virgil A S H Dalm, Sigrid P M A Oomen, Diana M Mooij, P Martin van Hagen, Steven W J Lamberts, Leo J Hofland
Publikováno v:
European Journal of Endocrinology; Apr2004, Vol. 150 Issue 4, p0565-0577, 13p